Contributions of risk factors and medical care to cardiovascular mortality trends

被引:236
作者
Ezzati, Majid [1 ]
Obermeyer, Ziad [2 ]
Tzoulaki, Ioanna [1 ]
Mayosi, Bongani M. [3 ,4 ]
Elliott, Paul [1 ]
Leon, David A. [5 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, Sch Publ Hlth, Norfolk Pl, London W2 1PG, England
[2] Harvard Univ, Dept Emergency Med, Sch Med, Boston, MA 02115 USA
[3] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa
[4] Univ Cape Town, ZA-7925 Cape Town, South Africa
[5] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Sci, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; SMOKING-ATTRIBUTABLE MORTALITY; NATIONAL NUTRITION SURVEY; CARBON-MONOXIDE YIELDS; ACUTE RHEUMATIC-FEVER; CASE-FATALITY RATES; BODY-MASS INDEX; UNITED-STATES; BLOOD-PRESSURE;
D O I
10.1038/nrcardio.2015.82
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ischaemic heart disease, stroke, and other cardiovascular diseases (CVDs) lead to 17.5 million deaths worldwide per year. Taking into account population ageing, CVD death rates are decreasing steadily both in regions with reliable trend data and globally. The declines in high-income countries and some Latin American countries have been ongoing for decades without slowing. These positive trends have broadly coincided with, and benefited from, declines in smoking and physiological risk factors, such as blood pressure and serum cholesterol levels. These declines have also coincided with, and benefited from, improvements in medical care, including primary prevention, diagnosis, and treatment of acute CVDs, as well as post-hospital care, especially in the past 40 years. These variables, however, explain neither why the decline began when it did, nor the similarities and differences in the start time and rate of the decline between countries and sexes. In Russia and some other former Soviet countries, changes in volume and patterns of alcohol consumption have caused sharp rises in CVD mortality since the early 1990s. An important challenge in reaching firm conclusions about the drivers of these remarkable international trends is the paucity of time-trend data on CVD incidence, risk factors throughout the life-course, and clinical care.
引用
收藏
页码:508 / 530
页数:23
相关论文
共 320 条
  • [51] Glycemic targets and cardiovascular disease
    Cefalu, William T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) : 2633 - 2635
  • [52] Charlton J., 1997, HLTH ADULT BRITAIN 1, V2, P60
  • [53] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [54] Cholesterol Treatment Trialists' (CTT) Collaboration, 2010, LANCET, V366, P1267
  • [55] Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries
    Chow, Clara K.
    Teo, Koon K.
    Rangarajan, Sumathy
    Islam, Shofiqul
    Gupta, Rajeev
    Avezum, Alvaro
    Bahonar, Ahmad
    Chifamba, Jephat
    Dagenais, Gilles
    Diaz, Rafael
    Kazmi, Khawar
    Lanas, Fernando
    Wei, Li
    Lopez-Jaramillo, Patricio
    Lu Fanghong
    Ismail, Noor Hassim
    Puoane, Thandi
    Rosengren, Annika
    Szuba, Andrzej
    Temizhan, Ahmet
    Wielgosz, Andy
    Yusuf, Rita
    Yusufali, Afzalhussein
    Mckee, Martin
    Liu, Lisheng
    Mony, Prem
    Yusuf, Salim
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (09): : 959 - 968
  • [56] Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk A Systematic Review and Meta-analysis
    Chowdhury, Rajiv
    Warnakula, Samantha
    Kunutsor, Setor
    Crowe, Francesca
    Ward, Heather A.
    Johnson, Laura
    Franco, Oscar H.
    Butterworth, Adam S.
    Forouhi, Nita G.
    Thompson, Simon G.
    Khaw, Kay-Tee
    Mozaffarian, Dariush
    Danesh, John
    Di Angelantonio, Emanuele
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 160 (06) : 398 - +
  • [57] Cipriani F., 2007, CONTEMP DRUG PROBL, V34, P361, DOI [DOI 10.1177/009145090703400213, 10.1177/009145090703400213]
  • [58] Methodological Issues in Cohort Studies That Relate Sodium Intake to Cardiovascular Disease Outcomes A Science Advisory From the American Heart Association
    Cobb, Laura K.
    Anderson, Cheryl A. M.
    Elliott, Paul
    Hu, Frank B.
    Liu, Kiang
    Neaton, James D.
    Whelton, Paul K.
    Woodward, Mark
    Appel, Lawrence J.
    [J]. CIRCULATION, 2014, 129 (10) : 1173 - U254
  • [59] Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)
    Cook, Nancy R.
    Cutler, Jeffrey A.
    Obarzanek, Eva
    Buring, Julie E.
    Rexrode, Kathryn M.
    Kumanyika, Shiriki K.
    Appel, Lawrence J.
    Whelton, Paul K.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7599): : 885 - 888B
  • [60] Joint Effects of Sodium and Potassium Intake on Subsequent Cardiovascular Disease The Trials of Hypertension Prevention Follow-up Study
    Cook, Nancy R.
    Obarzanek, Eva
    Cutler, Jeffrey A.
    Buring, Julie E.
    Rexrode, Kathryn M.
    Kumanyika, Shiriki K.
    Appel, Lawrence J.
    Whelton, Paul K.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (01) : 32 - 40